Financials Bright Minds Biosciences Inc.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 20:48:09 06/02/2026 GMT			5-day change	1st Jan Change
104.31 ^CAD	0.00%		-2.94%	-5.54%

01-09	Bright Minds Biosciences Closes its US$175 Million Public Offering	MT
01-09	Bright Minds Biosciences Closes $175.1 Million Stock Offering	MT

Fiscal Period: September	2021	2023	2024	2025	2026	2027	2028
Net sales ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
EBITDA ¹	-	-	-	-13.67	-103.4	-206.8	-289.6
Change	-	-	-	-	-656.29%	-100%	-40.04%
EBIT ¹	-	-	-	-13.75	-84.47	-183.3	-233.3
Change	-	-	-	-	-514.39%	-116.98%	-27.31%
Interest Paid	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	-	-12.23	-82.77	-180.6	-214.8
Change	-	-	-	-	-576.79%	-118.15%	-18.99%
Net income ¹	-	-7.372	-	-12.23	-82.77	-180.6	-214.8
Change	-	-	-	-	-576.79%	-118.15%	-18.99%
Announcement Date	29/12/21	29/12/23	31/12/24	24/12/25	-	-	-

¹CAD in Million

Estimates

Fiscal Period: September	2021 Q4	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA ¹	-	-	-	-1.603	-3.437	-5.961	-4.34	-14.9	-22.2	-29.5	-36.8	-	-	-	-
Change	-	-	-	-	-114.41%	-73.43%	27.19%	-243.3%	-48.99%	-32.88%	-24.75%	-	-	-	-
EBIT ¹	-	-	-	0.0453	-3.46	-5.977	-4.357	-11.62	-20.5	-27	-34.37	-34.18	-40.64	-47.68	-55.32
Change	-	-	-	-	-7,739.15%	-72.76%	27.1%	-166.57%	-76.51%	-31.7%	-27.28%	0.53%	-18.88%	-17.32%	-16.02%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	-	0.0496	-2.95	-5.501	-3.828	-11.28	-20.19	-26.24	-33.65	-32.89	-39.51	-46.04	-53.92
Change	-	-	-	-	-6,047.17%	-86.44%	30.42%	-194.58%	-79.05%	-29.96%	-28.25%	2.27%	-20.15%	-16.5%	-17.12%
Net income ¹	-	0.2299	-	0.0496	-2.95	-5.243	-4.086	-10.58	-18.46	-24.27	-28.84	-32.89	-39.51	-46.04	-53.92
Change	-	-	-	-	-6,047.17%	-77.7%	22.07%	-158.94%	-74.5%	-31.47%	-18.84%	-14.02%	-20.15%	-16.5%	-17.12%
Announcement Date	29/12/21	14/08/24	31/12/24	13/02/25	15/05/25	14/08/25	24/12/25	-	-	-	-	-	-	-	-

¹CAD in Million

Estimates

Fiscal Period: September	2021	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	29/12/21	29/12/23	31/12/24	24/12/25	-	-	-

Estimates

Fiscal Period: September	2025	2026	2027	2028
CAPEX ¹	-	-	-	-
Change	-	-	-	-
Free Cash Flow (FCF) ¹	-8.692	-96.6	-190.6	-256.5
Change	-	-1,011.42%	-97.3%	-34.59%
Announcement Date	24/12/25	-	-	-

¹CAD in Million

Estimates

Fiscal Period: September	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-	-	-	-
EBT Margin (%)	-	-	-	-	-	-	-	-	-
Net margin (%)	-	-	-	-	-	-	-	-	-
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	71.07%	116.71%	105.56%	119.4%
Profitability
ROA	-61.7%	-51.52%	-57.32%	-47.45%	-25.19%	-18.8%	-	-	-
ROE	-124.04%	-85.94%	-99.95%	-86.02%	-46.18%	-27.93%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-	-	-1.98	-	-1.78	-7.746	-13.04	-13.11
Change	-	-	-	-	-	-	-335.15%	-68.38%	-0.54%
Nbr of stocks (in thousands)	-	-	-	3,772	-	7,089	9,732	9,732	9,732
Announcement Date	-	-	-	29/12/23	-	24/12/25	-	-	-